Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

NUMI

Numinus Wellness (NUMI)

Numinus Wellness Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:TSX:NUMI
DataHoraFonteTítuloCódigoCompanhia
07/06/202408:27PR Newswire (Canada)Numinus Wellness Comments on FDA Advisory Committee Meeting for Investigational MDMA-Assisted Therapy for PTSDTSX:NUMINuminus Wellness Inc
31/05/202420:38PR Newswire (US)Numinus Wellness Announces Voting Results From its Annual General Meeting of ShareholdersTSX:NUMINuminus Wellness Inc
30/05/202408:00PR Newswire (Canada)Numinus Wellness Receives Health Canada Approval for Study into Group Model for MDMA-Assisted TherapyTSX:NUMINuminus Wellness Inc
07/05/202408:00PR Newswire (US)Numinus Wellness Focused on Boosting Profitability and Expanding Community SupportTSX:NUMINuminus Wellness Inc
17/04/202408:00PR Newswire (US)Cedar Clinical Research selected as clinical research site for Cybin's Phase 3 Study of CYB003TSX:NUMINuminus Wellness Inc
15/04/202408:41PR Newswire (US)Numinus Wellness Provides Corporate UpdateTSX:NUMINuminus Wellness Inc
12/04/202420:49PR Newswire (Canada)Numinus Wellness Inc. Announces Second Quarter Fiscal 2024 ResultsTSX:NUMINuminus Wellness Inc
09/04/202408:00PR Newswire (US)Numinus to Host Q2 Fiscal 2024 Results Conference Call on April 15, 2024TSX:NUMINuminus Wellness Inc
20/03/202408:00PR Newswire (US)Numinus Wellness Submits Clinical Trial ApplicationTSX:NUMINuminus Wellness Inc
08/03/202409:00PR Newswire (Canada)Numinus Wellness Congratulates MindMed on Positive Results from Phase 2B Clinical Trials of MM120 for Generalized Anxiety DisorderTSX:NUMINuminus Wellness Inc
16/02/202412:29PR Newswire (Canada)Numinus Wellness Inc. Closes $6 Million Bought Deal Public OfferingTSX:NUMINuminus Wellness Inc
14/02/202412:39PR Newswire (Canada)Numinus Wellness Inc. Congratulates Lykos Therapeutics on FDA Acceptance of New Drug Application for MDMA-Assisted Therapy for PTSDTSX:NUMINuminus Wellness Inc
02/02/202410:07PR Newswire (Canada)L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - NUMITSX:NUMINuminus Wellness Inc
02/02/202410:06PR Newswire (Canada)Canadian Investment Regulatory Organization Trade Resumption - NUMITSX:NUMINuminus Wellness Inc
01/02/202418:50PR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - NUMITSX:NUMINuminus Wellness Inc
01/02/202418:41PR Newswire (Canada)Canadian Investment Regulatory Organization Trading Halt - NUMITSX:NUMINuminus Wellness Inc
01/02/202416:59PR Newswire (US)/C O R R E C T I O N from Source -- Numinus Wellness Inc./TSX:NUMINuminus Wellness Inc
01/02/202409:00PR Newswire (US)Numinus Wellness Divests of Holdings in Alto Neuroscience Inc.TSX:NUMINuminus Wellness Inc
15/01/202419:00PR Newswire (US)Numinus Wellness Inc. Announces First Quarter Fiscal 2024 ResultsTSX:NUMINuminus Wellness Inc
02/01/202419:00PR Newswire (US)Numinus to Host Q1 Fiscal 2024 Results Conference Call on January 15, 2024TSX:NUMINuminus Wellness Inc
15/12/202312:26PR Newswire (US)Cedar Clinical Research selected as clinical research site for Beckley Psytech's Phase 2b StudyTSX:NUMINuminus Wellness Inc
13/12/202309:00PR Newswire (US)Numinus Congratulates MAPS on its Application to the FDA for MDMA-Assisted Therapy for PTSDTSX:NUMINuminus Wellness Inc
29/11/202319:00PR Newswire (US)Numinus Wellness Inc. Announces Fourth Quarter and Full Year Fiscal 2023 ResultsTSX:NUMINuminus Wellness Inc
21/11/202310:00PR Newswire (US)Numinus to Host Q4 2023 and Annual Results Conference Call on November 29, 2023TSX:NUMINuminus Wellness Inc
03/10/202308:00PR Newswire (US)Numinus Announces Psychedelic Program for Mental Distress Associated with Chronic and Serious Illness through Cedar Clinical ResearchTSX:NUMINuminus Wellness Inc
25/09/202320:16PR Newswire (Canada)Numinus Wellness Inc. Announces At-The-Market Offering Equity ProgramTSX:NUMINuminus Wellness Inc
19/09/202308:00PR Newswire (Canada)Numinus Congratulates MAPS on its Phase 3 Study Results Published in Nature MedicineTSX:NUMINuminus Wellness Inc
18/09/202319:45PR Newswire (Canada)Numinus Takes Actions to Accelerate its Path to Profitability by Focusing on Positive Cash Flow Generating OperationsTSX:NUMINuminus Wellness Inc
09/08/202308:00PR Newswire (US)Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, August 17, 2023TSX:NUMINuminus Wellness Inc
17/07/202317:01PR Newswire (US)Numinus Wellness Inc. Reports Q3 2023 ResultsTSX:NUMINuminus Wellness Inc
 Apresentando as notícias mais relevantes sobre:TSX:NUMI